Monthly Archives: July 2017

The polygamous town facing genetic disaster – BBC News

Posted: July 26, 2017 at 3:48 pm


BBC News
The polygamous town facing genetic disaster
BBC News
That's because genetic information is useless on its own. To be meaningful to medical research, it must be linked to information about disease. In fact, more human disease genes have been discovered in Utah with its Mormon history than any other ...

Visit link:
The polygamous town facing genetic disaster - BBC News

Posted in Human Genetics | Comments Off on The polygamous town facing genetic disaster – BBC News

DNA virus – Wikipedia

Posted: at 3:47 pm

A DNA virus is a virus that has DNA as its genetic material and replicates using a DNA-dependent DNA polymerase. The nucleic acid is usually double-stranded DNA (dsDNA) but may also be single-stranded DNA (ssDNA). DNA viruses belong to either Group I or Group II of the Baltimore classification system for viruses. Single-stranded DNA is usually expanded to double-stranded in infected cells. Although Group VII viruses such as hepatitis B contain a DNA genome, they are not considered DNA viruses according to the Baltimore classification, but rather reverse transcribing viruses because they replicate through an RNA intermediate. Notable diseases like smallpox, herpes, and chickenpox are caused by such DNA viruses.

Genome organization within this group varies considerably. Some have circular genomes (Baculoviridae, Papovaviridae and Polydnaviridae) while others have linear genomes (Adenoviridae, Herpesviridae and some phages). Some families have circularly permuted linear genomes (phage T4 and some Iridoviridae). Others have linear genomes with covalently closed ends (Poxviridae and Phycodnaviridae).

A virus infecting archaea was first described in 1974. Several others have been described since: most have head-tail morphologies and linear double-stranded DNA genomes. Other morphologies have also been described: spindle shaped, rod shaped, filamentous, icosahedral and spherical. Additional morphological types may exist.

Orders within this group are defined on the basis of morphology rather than DNA sequence similarity. It is thought that morphology is more conserved in this group than sequence similarity or gene order which is extremely variable. Three orders and 31 families are currently recognised. A fourth orderMegaviralesfor the nucleocytoplasmic large DNA viruses has been proposed.[1] Four genera are recognised that have not yet been assigned a family.

Fifteen families are enveloped. These include all three families in the order Herpesvirales and the following families: Ascoviridae, Ampullaviridae, Asfarviridae, Baculoviridae, Fuselloviridae, Globuloviridae, Guttaviridae, Hytrosaviridae, Iridoviridae, Lipothrixviridae, Nimaviridae and Poxviridae.

Bacteriophages (viruses infecting bacteria) belonging to the families Tectiviridae and Corticoviridae have a lipid bilayer membrane inside the icosahedral protein capsid and the membrane surrounds the genome. The crenarchaeal virus Sulfolobus turreted icosahedral virus has a similar structure.

The genomes in this group vary considerably from ~10 kilobases to over 2.5 megabases in length. The largest bacteriophage known is Klebsiella Phage vB_KleM-RaK2 which has a genome of 346 kilobases.[2]

A recently proposed clade is the Megavirales which includes the nucleocytoplasmic large DNA viruses.[1][3] This proposal has yet to be ratified by the ICTV.

The virophages are a group of viruses that infect other viruses. Their classification has yet to be decided. A family Lavidaviridae has been proposed for the genera Mavirus and Sputnikvirus.[4]

A virus with a novel method of genome packing infecting species of the genus Sulfolobus has been described.[5] As this virus does not resemble any known virus it seems likely that a new family will be created for it.

Species of the order Caudovirales and of the families Corticoviridae and Tectiviridae infect bacteria.

Species of the order Ligamenvirales and the families Ampullaviridae, Bicaudaviridae, Clavaviridae, Fuselloviridae, Globuloviridae, Guttaviridae and Turriviridae infect hyperthermophilic archaea species of the Crenarchaeota.

Species of the order Herpesvirales and of the families Adenoviridae, Asfarviridae, Iridoviridae, Papillomaviridae, Polyomaviridae and Poxviridae infect vertebrates.

Species of the families Ascovirus, Baculovirus, Hytrosaviridae, Iridoviridae and Polydnaviruses and of the genus Nudivirus infect insects.

Species of the family Mimiviridae and the species Marseillevirus, Megavirus, Mavirus virophage and Sputnik virophage infect protozoa.

Species of the family Nimaviridae infect crustaceans.

Species of the family Phycodnaviridae and the species Organic Lake virophage infect algae. These are the only known dsDNA viruses that infect plants.

Species of the family Plasmaviridae infect species of the class Mollicutes.

Species of the family Pandoraviridae infect amoebae.

Species of the genus Dinodnavirus infect dinoflagellates. These are the only known viruses that infect dinoflagellates.

Species of the genus Rhizidiovirus infect stramenopiles. These are the only known dsDNA viruses that infect stramenopiles.

Species of the genus Salterprovirus and Sphaerolipoviridae infect species of the Euryarchaeota.

A group known as the pleolipoviruses, although having a similar genome organisation, differ in having either single or double stranded DNA genomes.[6] Within the double stranded forms have runs of single stranded DNA.[7] These viruses have been placed in the family Pleolipoviridae.[8] This family has been divided in three genera: Alphapleolipovirus, Betapleolipovirus and Gammapleolipovirus.

These viruses are nonlytic and form virions characterized by a lipid vesicle enclosing the genome.[9] They do not have nucleoproteins. The lipids in the viral membrane are unselectively acquired from host cell membranes. The virions contain two to three major structural proteins, which either are embedded in the membrane or form spikes distributed randomly on the external membrane surface.

This group includes the following viruses:

Although bacteriophages were first described in 1927, it was only in 1959 that Sinshemer working with phage Phi X 174 showed that they could possess single-stranded DNA genomes.[10][11] Despite this discovery until relatively recently it was believed that the majority of DNA viruses belonged to the double-stranded clade. Recent work suggests that this may not be the case with single-stranded viruses forming the majority of viruses found in sea water, fresh water, sediment, terrestrial, extreme, metazoan-associated and marine microbial mats.[12][13] Many of these "environmental" viruses belong to the family Microviridae.[14] However, the vast majority has yet to be classified and assigned to genera and higher taxa. Because most of these viruses do not appear to be related or are only distantly related to known viruses additional taxa will be created for these.

Although ~50 archaeal viruses are known, all but two have double stranded genomes. These two viruses have been placed in the families Pleolipoviridae and Spiraviridae

Families in this group have been assigned on the basis of the nature of the genome (circular or linear) and the host range. Ten families are currently recognised.

A division of the circular single stranded viruses into four types has been proposed.[15] This division seems likely to reflect their phylogenetic relationships.

Type I genomes are characterized by a small circular DNA genome (approximately 2-kb), with the Rep protein and the major open reading frame (ORF) in opposite orientations. This type is characteristic of the circoviruses, geminiviruses and nanoviruses.

Type II genomes have the unique feature of two separate Rep ORFs.

Type III genomes contain two major ORFs in the same orientation. This arrangement is typical of the anelloviruses.

Type IV genomes have the largest genomes of nearly 4-kb, with up to eight ORFs. This type of genome is found in the Inoviridae and the Microviridae.

Given the variety of single stranded viruses that have been described this schemeif it is accepted by the ICTVwill need to be extended.

The families Bidnaviridae and Parvoviridae have linear genomes while the other families have circular genomes. The Bidnaviridae have a two part genome and infect invertebrates. The Inoviridae and Microviridae infect bacteria; the Anelloviridae and Circoviridae infect animals (mammals and birds respectively); and the Geminiviridae and Nanoviridae infect plants. In both the Geminiviridae and Nanoviridae the genome is composed of more than a single chromosome. The Bacillariodnaviridae infect diatoms and have a unique genome: the major chromosome is circular (~6 kilobases in length): the minor chromosome is linear (~1 kilobase in length) and complementary to part of the major chromosome. Members of the Spiraviridae infect archaea. Members of the Genomoviridae infect fungi.

All viruses in this group require formation of a replicative forma double stranded DNA intermediatefor genome replication. This is normally created from the viral DNA with the assistance of the host's own DNA polymerase.

In the 9th edition of the viral taxonomy of the ICTV (published 2011) the Bombyx mori densovirus type 2 was placed in a new familythe Bidnaviridae on the basis of its genome structure and replication mechanism. This is currently the only member of this family but it seems likely that other species will be allocated to this family in the near future.

A new genus Bufavirus was proposed on the basis of the isolation of two new viruses from human stool.[16] Another member of this genusmegabat bufavius 1has been reported from bats.[17] The human viruses have since been renamed Primate protoparvovirus and been placed in the genus Protoparvovirus.[18][19]

The most recently introduced family of ssDNA viruses is the Genomoviridae (the family name is an acronym derived from geminivirus-like, no movement protein).[20]

The family includes 9 genera, namely Gemycircularvirus, Gemyduguivirus, Gemygorvirus, Gemykibivirus, Gemykolovirus, Gemykrogvirus, Gemykroznavirus, Gemytondvirus and Gemyvongvirus.[21]

The genus name Gemycircularvirus stands for Gemini-like myco-infecting circular virus.[22][23] the type species of the genus Gemycircularvirus - Sclerotinia sclerotiorum hypovirulence associated DNA virus 1 - is currently the only cultivated member of the family.[20] The rest of genomoviruses are uncultivated and have been discovered using metagenomics techniques.[21]

Isolates from this group have also been isolated from the cerebrospinal fluid and brains of patients with multiple sclerosis.[24]

A isolate from this group has also been identified in a child with encephalitis.[25]

Viruses from this group have also been isolated from the blood of HIV+ve patients.[26]

Ostrich faecal associated ssDNA virus has been placed in the genus Gemytondvirus. Rabbit faecal associated ssDNA virus has been placed in the genus Gemykroznavirus.

Another virus from this group has been isolated from mosquitoes.[27]

Ten new circular viruses have been isolated from dragonfly larvae.[28] The genomes range from 1628 to 2668 nucleotides in length. These dragonfly viruses have since been placed in the Gemycircularviridae.

Additional viruses from this group have been reported from dragonflies and damselflies.[29]

Three viruses in this group have been isolated from plants.[30]

A virus Cassava associated circular DNA virus that has some similarity to Sclerotinia sclerotiorum hypovirulence associated DNA virus 1 has been isolated.[31] This virus has been placed in the Gemycircularviridae.

Some of this group of viruses may infect fungi.[32]

A number of additional single stranded DNA viruses have been described but are as yet unclassified.

Viruses in this group have been isolated from other cases of encephalitis, diarrhoea and sewage.[33]

Two viruses have been isolated from human faeces circo-like virus Brazil hs1 and hs2 with genome lengths of 2526 and 2533 nucleotides respectively.[34] These viruses have four open reading frames. These viruses appear to be related to three viruses previously isolated from waste water, a bat and from a rodent.[35] This appears to belong to a novel group.

A novel species of virus - human respiratory-associated PSCV-5-like virus - has been isolated from the respiratory tract.[36] The virus is approximately 3 kilobases in length and has two open reading frames - one encoding the coat protein and the other the DNA replicase. The significance - if any - of this virus for human disease is unknown presently.

An unrelated group of ssDNA viruses, also discovered using viral metagenomics, includes the species bovine stool associated circular virus and chimpanzee stool associated circular virus.[37] The closest relations to this genus appear to be the Nanoviridae but further work will be needed to confirm this. Another isolate that appears to be related to these viruses has been isolated from pig faeces in New Zealand.[38] This isolate also appears to be related to the pig stool-associated single-stranded DNA virus. This virus has two large open reading frames one encoding the capsid gene and the other the Rep gene. These are bidirectionally transcribed and separated by intergenic regions. Another virus of this group has been reported again from pigs.[39] A virus from this group has been isolated from turkey faeces.[40] Another ten viruses from this group have been isolated from pig faeces.[41] Viruses that appear to belong to this group have been isolated from other mammals including cows, rodents, bats, badgers and foxes.[32]

Another virus in this group has been isolated from birds.[42]

Fur seal feces-associated circular DNA virus was isolated from the faeces of a fur seal (Arctocephalus forsteri) in New Zealand.[43] The genome has 2 main open reading frames and is 2925 nucleotides in length. Another virus - porcine stool associated virus 4[44] - has been isolated. It appears to be related to the fur seal virus.

Two viruses have been described from the nesting material yellow crowned parakeet (Cyanoramphus auriceps) Cyanoramphus nest-associated circular X virus (2308 nt) and Cyanoramphus nest-associated circular K virus (2087 nt)[45] Both viruses have two bidirectional open reading frames. Within these are the rolling-circle replication motifs I, II, III and the helicase motifs Walker A and Walker B. There is also a conserved nonanucleotide motif required for rolling-circle replication. CynNCKV has some similarity to the picobiliphyte nano-like virus (Picobiliphyte M5584-5)[46] and CynNCXV has some similarity to the rodent stool associated virus (RodSCV M-45).[47]

A virus with a circular genome sea turtle tornovirus 1 has been isolated from a sea turtle with fibropapillomatosis.[48] It is sufficiently unrelated to any other known virus that it may belong to a new family. The closest relations seem to be the Gyrovirinae. The proposed genus name for this virus is Tornovirus.

Among these are the parvovirus-like viruses. These have linear single-stranded DNA genomes but unlike the parvoviruses the genome is bipartate. This group includes Hepatopancreatic parvo-like virus and Lymphoidal parvo-like virus. A new family Bidensoviridae has been proposed for this group but this proposal has not been ratified by the ICTV to date.[49] Their closest relations appear to be the Brevidensoviruses (family Parvoviridae).[50]

A virus Acheta domesticus volvovirus - has been isolated from the house cricket (Acheta domesticus).[51] The genome is circular, has four open reading frames and is 2,517 nucleotides in length. It appears to be unrelated to previously described species. The genus name Volvovirus has been proposed for these species.[52] The genomes in this genus are ~2.5 nucleotides in length and encode 4 open reading frames.

Two new viruses have been isolated from the copepods Acartia tonsa and Labidocera aestiva Acartia tonsa copepod circo-like virus and Labidocera aestiva copepod circo-like virus respectively.

A virus has been isolated from the mud flat snail (Amphibola crenata).[53] This virus has a single stranded circular genome of 2351 nucleotides that encoded 2 open reading frames that are oriented in opposite directions. The smaller open reading frame (874 nucleotides) encodes a protein with similarities to the Rep (replication) proteins of circoviruses and plasmids. The larger open reading frame (955 nucleotides) has no homology to any currently known protein.

An unusual and as yet unnamed virus has been isolated from the flatwom Girardia tigrina.[54] Because of its genome organisation, this virus appears to belong to an entirely new family. It is the first virus to be isolated from a flatworm.

From the hepatopancreas of the shrimp (Farfantepenaeus duorarum) a circular single stranded DNA virus has been isolated.[55] This virus does not appear to cause disease in the shrimp.

A circo-like virus has been isolated from the shrimp (Penaeus monodon).[56] The 1,777-nucleotide genome is circular and single stranded. It has some similarity to the circoviruses and cycloviruses.

Ten viruses have been isolated from echinoderms.[57] All appear to belong to as yet undescribed genera.

A circular single stranded DNA virus has been isolated from a grapevine.[58] This species may be related to the family Geminiviridae but differs from this family in a number of important respects including genome size.

Several viruses baminivirus, nepavirus and niminivirus related to geminvirus have also been reported.[32]

A virus - Ancient caribou feces associated virus - has been cloned from 700-y-old caribou faeces.[59]

More than 600 single-stranded DNA viral genomes were identified in ssDNA purified from seawater .[60] These fell into 129 genetically distinct groups that had no recognizable similarity to each other or to other virus sequences, and thus many likely represent new families of viruses. Of the 129 groups, eleven were much more abundant than the others, and although their hosts have yet to be identified, they are likely to be eukaryotic phytoplankton, zooplankton and bacteria.

A virus Boiling Springs Lake virus appears to have evolved by a recombination event between a DNA virus (circovirus) and an RNA virus (tombusvirus).[61] The genome is circular and encodes two proteinsa Rep protein and a capsid protein.

Further reports of viruses that appear to have evolved from recombination events between ssRNA and ssDNA viruses have been made.[62]

A new virus has been isolated from the diatom Chaetoceros setoensis.[63] It has a single stranded DNA genome and does not appear to be a member of any previously described group.

A virus - FLIP (Flavobacterium-infecting, lipid-containing phage) - has been isolated from a lake.[64] This virus has a circular ssDNA genome (9,174 nucleotides) and an internal lipid membrane enclosed in a icosahedral capsid. The capsid organisation is he capsid organization pseudo T = 21 dextro. The major capsid protein has two -barrels. The capsid organisation is similar to bacteriophage PM2 - a double stranded bacterial virus.

Satellite viruses are small viruses with either RNA or DNA as their genomic material that require another virus to replicate. There are two types of DNA satellite virusesthe alphasatellites and the betasatellitesboth of which are dependent on begomoviruses. At present satellite viruses are not classified into genera or higher taxa.

Alphasatellites are small circular single strand DNA viruses that require a begomovirus for transmission. Betasatellites are small linear single stranded DNA viruses that require a begomovirus to replicate.

Phylogenetic relationships between these families are difficult to determine. The genomes differ significantly in size and organisation. Most studies that have attempted to determine these relationships are based either on some of the more conserved proteinsDNA polymerase and othersor on common structural features. In general most of the proposed relationships are tentative and have not yet been used by the ICTV in their classification.

While determining the phylogenetic relations between the various known clades of viruses is difficult, on a number of grounds the herpesviruses and caudoviruses appear to be related.

While the three families in the order Herpesvirales are clearly related on morphological grounds, it has proven difficult to determine the dates of divergence between them because of the lack of gene conservation.[65] On morphological grounds they appear to be related to the bacteriophagesspecifically the Caudoviruses.

The branching order among the herpesviruses suggests that Alloherpesviridae is the basal clade and that Herpesviridae and Malacoherpesviridae are sister clades.[66] Given the phylogenetic distances between vertebrates and molluscs this suggests that herpesviruses were initially fish viruses and that they have evolved with their hosts to infect other vertebrates.

The vertebrate herpesviruses initially evolved ~400 million years ago and underwent subsequent evolution on the supercontinent Pangaea.[67] The alphaherpesvirinae separated from the branch leading to the betaherpesvirinae and gammaherpesvirinae about 180 million years ago to 220 million years ago.[68] The avian herpes viruses diverged from the branch leading to the mammalian species.[69] The mammalian species divided into two branchesthe Simplexvirus and Varicellovirus genera. This latter divergence appears to have occurred around the time of the mammalian radiation.

Several dsDNA bacteriophages and the herpesviruses encode a powerful ATP driven DNA translocating machine that encapsidates a viral genome into a preformed capsid shell or prohead. The critical components of the packaging machine are the packaging enzyme (terminase) which acts as the motor and the portal protein that forms the unique DNA entrance vertex of prohead. The terminase complex consists of a recognition subunit (small terminase) and an endonuclease/translocase subunit (large terminase) and cuts viral genome concatemers. It forms a motor complex containing five large terminase subunits. The terminase-viral DNA complex docks on the portal vertex. The pentameric motor processively translocates DNA until the head shell is full with one viral genome. The motor cuts the DNA again and dissociates from the full head, allowing head-finishing proteins to assemble on the portal, sealing the portal, and constructing a platform for tail attachment. Only a single gene encoding the putative ATPase subunit of the terminase (UL15) is conserved among all herpesviruses. To a lesser extent this gene is also found in T4-like bacteriophages suggesting a common ancestor for these two groups of viruses.[70] Another paper has also suggested that herpesviruses originated among the bacteriophages.[71]

A common origin for the herpesviruses and the caudoviruses has been suggested on the basis of parallels in their capsid assembly pathways and similarities between their portal complexes, through which DNA enters the capsid.[72] These two groups of viruses share a distinctive 12-fold arrangement of subunits in the portal complex. A second paper has suggested an evolutionary relationship between these two groups of viruses.[71]

It seems likely that the tailed viruses infecting the archaea are also related to the tailed viruses infecting bacteria.[73][74]

The nucleocytoplasmic large DNA virus group (Asfarviridae, Iridoviridae, Marseilleviridae, Mimiviridae, Phycodnaviridae and Poxviridae) along with three other familiesAdenoviridae, Cortiviridae and Tectiviridae and the phage Sulfolobus turreted icosahedral virus and the satellite virus Sputnik all possess double -barrel major capsid proteins suggesting a common origin.[75]

Several studies have suggested that the family Ascoviridae evolved from the Iridoviridae.[76][77][78][79] A study of the Iridoviruses suggests that the Iridoviridae, Ascoviridae and Marseilleviridaeare are related with Ascoviruses most closely related to Iridoviruses.[80]

The family Polydnaviridae may have evolved from the Ascoviridae.[81] Molecular evidence suggests that the Phycodnaviridae may have evolved from the family Iridoviridae.[82] These four families (Ascoviridae, Iridoviridae, Phycodnaviridae and Polydnaviridae) may form a clade but more work is needed to confirm this.

Some of the relations among the large viruses have been established.[83] Mimiviruses are distantly related to Phycodnaviridae. Pandoraviruses share a common ancestor with Coccolithoviruses within the Phycodnaviridae family.[84] Pithoviruses are related to Iridoviridae and Marseilleviridae.

Based on the genome organisation and DNA replication mechanism it seems that phylogenetic relationships may exist between the rudiviruses (Rudiviridae) and the large eukaryal DNA viruses: the African swine fever virus (Asfarviridae), Chlorella viruses (Phycodnaviridae) and poxviruses (Poxviridae).[85]

Based on the analysis of the DNA polymerase the genus Dinodnavirus may be a member of the family Asfarviridae.[86] Further work on this virus will required before a final assignment can be made.

Based on the analysis of the coat protein, Sulfolobus turreted icosahedral virus may share a common ancestry with the Tectiviridae.

The families Adenoviridae and Tectiviridae appear to be related structurally.[87]

Baculoviruses evolved from the nudiviruses 310 million years ago.[88][89]

The Hytrosaviridae are related to the baculoviruses and to a lesser extent the nudiviruses suggesting they may have evolved from the baculoviruses.[90]

The Nimaviridae may be related to nudiviruses and baculoviruses.[91]

The Nudiviruses seem to be related to the polydnaviruses.[92]

A protein common to the families Bicaudaviridae, Lipotrixviridae and Rudiviridae and the unclassified virus Sulfolobus turreted icosahedral virus is known suggesting a common origin.[93]

Examination of the pol genes that encode the DNA dependent DNA polymerase in various groups of viruses suggests a number of possible evolutionary relationships.[94] All know viral DNA polymerases belong to the DNA pol families A and B. All possess a 3'-5'-exonuclease domain with three sequence motifs Exo I, Exo II and Exo III. The families A and B are distinguishable with family A Pol sharing 9 distinct consensus sequences and only two of them are convincingly homologous to sequence motif B of family B. The putative sequence motifs A, B, and C of the polymerase domain are located near the C-terminus in family A Pol and more central in family B Pol.

Go here to read the rest:
DNA virus - Wikipedia

Posted in DNA | Comments Off on DNA virus – Wikipedia

Scientists build DNA from scratch to alter life’s blueprint – CBS News

Posted: at 3:47 pm

NEW YORK -- At Jef Boeke's lab, you can whiff an odor that seems out of place, as if they were baking bread here.

But he and his colleagues are cooking up something else altogether: yeast that works with chunks of man-made DNA.

Scientists have long been able to make specific changes in the DNA code. Now, they're taking the more radical step of starting over, and building redesigned life forms from scratch. Boeke, a researcher at New York University, directs an international team of 11 labs on four continents working to "rewrite" the yeast genome, following a detailed plan they published in March.

Their work is part of a bold and controversial pursuit aimed at creating custom-made DNA codes to be inserted into living cells to change how they function, or even provide a treatment for diseases. It could also someday help give scientists the profound and unsettling ability to create entirely new organisms.

The genome is the entire genetic code of a living thing. Learning how to make one from scratch, Boeke said, means "you really can construct something that's completely new."

The research may reveal basic, hidden rules that govern the structure and functioning of genomes. But it also opens the door to life with new and useful characteristics, like microbes or mammal cells that are better than current ones at pumping out medications in pharmaceutical factories, or new vaccines. The right modifications might make yeast efficiently produce new biofuels, Boeke says.

Some scientists look further into the future and see things like trees that purify water supplies and plants that detect explosives at airports and shopping malls.

Also on the horizon is redesigning human DNA. That's not to make genetically altered people, scientists stress. Instead, the synthetic DNA would be put into cells, to make them better at pumping out pharmaceutical proteins, for example, or perhaps to engineer stem cells as a safer source of lab-grown tissue and organs for transplanting into patients.

Some have found the idea of remaking human DNA disconcerting, and scientists plan to get guidance from ethicists and the public before they try it.

Still, redesigning DNA is alarming to some. Laurie Zoloth of Northwestern University, a bioethicist who's been following the effort, is concerned about making organisms with "properties we cannot fully know." And the work would disturb people who believe creating life from scratch would give humans unwarranted power, she said.

"It is not only a science project," Zoloth said in an email. "It is an ethical and moral and theological proposal of significant proportions."

Rewritten DNA has already been put to work in viruses and bacteria. Australian scientists recently announced that they'd built the genome of the Zika virus in a lab, for example, to better understand it and get clues for new treatments.

At Harvard University, Jeffrey Way and Pamela Silver are working toward developing a harmless strain of salmonella to use as a vaccine against food poisoning from salmonella and E. coli, as well as the diarrhea-causing disease called shigella.

A key goal is to prevent the strain from turning harmful as a result of picking up DNA from other bacteria. That requires changing its genome in 30,000 places.

"The only practical way to do that," Way says, "is to synthesize it from scratch."

The cutting edge for redesigning a genome, though, is yeast. Its genome is bigger and more complex than the viral and bacterial codes altered so far. But it's well-understood and yeast will readily swap man-made DNA for its own.

Still, rewriting the yeast genome is a huge job.

It's like a chain with 12 million chemical links, known by the letters, A, C, G and T. That's less than one-hundredth the size of the human genome, which has 3.2 billion links. But it's still such a big job that Boeke's lab and scientists in the United States, Australia, China, Singapore, and the United Kingdom are splitting up the work. By the time the new yeast genome is completed, researchers will have added, deleted or altered about a million DNA letters.

Boeke compares a genome to a book with many chapters, and researchers are coming out with a new edition, with chapters that allow the book to do something it couldn't do before.

To redesign a particular stretch of yeast DNA, scientists begin with its sequence of code letters - nature's own recipe. They load that sequence into a computer, then tell the computer to make specific kinds of changes. For example one change might let them rearrange the order of genes, which might reveal strategies to make yeast grow better, says NYU researcher Leslie Mitchell.

Once the changes are made, the new sequence used as a blueprint. It is sent to a company that builds chunks of DNA containing the new sequence. Then these short chunks are joined together in the lab to build ever longer strands.

The project has so far reported building about one-third of the yeast genome. Boeke hopes the rest of the construction will be done by the end of the year. But he says it will take longer to test the new DNA and fix problems, and to finally combine the various chunks into a complete synthetic genome.

Last year, Boeke and others announced a separate effort, what is now called Genome Project-write or GP-write . It is chiefly focused on cutting the cost of building and testing large genomes, including human ones, by more than 1,000-fold within 10 years. The project is still seeking funding.

In the meantime, leaders of GP-write have started discussions of ethical, legal and social issues. And they realize the idea of making a human genome is a sensitive one.

"The notion that we could actually write a human genome is simultaneously thrilling to some and not so thrilling to others," Boeke said. "So we recognize this is going to take a lot of discussion."

Follow this link:
Scientists build DNA from scratch to alter life's blueprint - CBS News

Posted in DNA | Comments Off on Scientists build DNA from scratch to alter life’s blueprint – CBS News

Judge OKs DNA testing in 1988 Lincoln murder case – Lincoln Journal Star

Posted: at 3:47 pm

A 63-year-old man serving a life sentence for the 1988 murder of a Lincoln woman has won a push to get new DNA testing on previously untested evidence that he thinks could clear him of the crime.

Herman Buckman has served more than 29 years for the first-degree murder of Denise Strawkowski. He is at the Nebraska State Penitentiary.

On Feb. 19, 1988, she was found dead in the front seat of her car in a ravine near U.S. 34 and Northwest 48th Street. Strawkowski had been shot twice in the head.

At a trial, prosecutors said Buckman had killed her over a drug debt. The Lancaster County jury found him guilty.

Last September, Buckman filed a motion for forensic DNA testing of biological material asking that testing be done on the victim's underwear, as well as the floor mat and steering wheel cover.

Buckman contends that the testing could point to someone else as her killer.

He said the state never tested the evidence before and that the floor mats and steering wheel cover hadn't shown up on an earlier inventory.

In an order late last week, Lancaster County District Judge Susan Strong sustained the motion over an objection by the County Attorney's office. And she appointed the Commission on Public Advocacy to represent Buckman.

It's not the first time Buckman has filed a petition under the DNA Testing Act, which enables convicted people to request DNA testing at state expense if it could lead to a new trial or to outright exoneration.

In 2004, he lost his bid for a new trial after testing on cigarette butts found at the crime scene were inconclusive.

At best, Buckman could neither be included or excluded as being a contributor of some of the genetic material found on the tested cigarettes, according to the Nebraska Supreme Court opinion.

In 2001, Buckman petitioned the Lancaster County District Court for DNA testing on bloodied clothing belonging to him, and on cigarette butts found in the back seat of the car in which Stawkowski was murdered.

A judge approved the testing, but the examination of the clothing found no blood traces to test; and testing on the cigarette butts was inconclusive, partly because of contamination during storage.

At the 1988 trial, an expert witness for the state testified the butts had blood substances consistent with Buckman's blood type.

The later tests found DNA from more than one person, one of whom could have been Buckman.

Read the original post:
Judge OKs DNA testing in 1988 Lincoln murder case - Lincoln Journal Star

Posted in DNA | Comments Off on Judge OKs DNA testing in 1988 Lincoln murder case – Lincoln Journal Star

NRGene & China’s Genosys Deliver Cotton Genome – Markets Insider

Posted: at 3:47 pm

NESS ZIONA, Israel, July 26, 2017 /PRNewswire/ --

NRGene, the worldwide leader in genomic assembly and analysis, and Genosys Inc. (TGS Singapore), a leading distributor of genomics technologies in China, have partnered to deliver two complete cotton genomes.

"We first sequenced upland cotton (Gossypium hirsutum) in 2015," said Professor Tianzhen Zhang at Zhejiang University. "Now, we wanted to leverage the advances in technology to get a more complete version of not only in Gossypium hirsutum, but also Gossypium barbadense. Therefore, we combined forces with NRGene to assemble more complete cotton genomes."

Upland cotton constitutes 90% of the global cotton grown around the world and is used to produce most of the world's clothing. Gossypium barbadense, also known as extra-long staple (ELS) cotton, is used in luxury cotton fabrics.

"We've been working very closely with Professor Zhang for this entire project, facilitating the process," said Flora Liew, Managing Director of Genosys Inc. (TGS Singapore). "We were amazed by both, the speed and high quality of the DeNovoMAGICTM results."

Upon completion of the comprehensive genomes, it will be quick and inexpensive to analyze the other thousands of varieties because the genomic infrastructure will already be in place.

NRGene's DeNovoMAGICTM 3.0 provided the genome assembly based on the raw sequence data. PanMAGICTM will be used to assemble the pan-genome. It compares all-to-all of the de-novo assemblies to get the best view of local differences such as SNPs, as well as global changes such as translocations and duplications of whole chromosomic regions and PAV/CNV/SV analysis.

"Cotton is one of the world's most important non-food agricultural crops," says NRGene CEO, Gil Ronen. "By delivering critical insights into its make-up, we're helping researchers develop healthier plants with higher yields that require fewer resources."

About NRGene NRGene is a genomic big data company developing cutting-edge software and algorithms to reveal the complexity and diversity of crop plants, animals, and aquatic organisms for supporting the most advanced and sophisticated breeding programs. NRGene tools have already been employed by some of the leading seed companies worldwide as well as the most influential research teams in academia. http://www.nrgene.com.

NRGene Contact Amy Kenigsberg K2 Global Communications rel="nofollow">amy@k2-gc.com +1-913-440-4072 (+7 ET) +972-9-794-1681 (+2 GMT)

SOURCE NRGene

More here:
NRGene & China's Genosys Deliver Cotton Genome - Markets Insider

Posted in Genome | Comments Off on NRGene & China’s Genosys Deliver Cotton Genome – Markets Insider

Juvenescence Limited – Artificial Intelligence to Discover Drugs in a Multi-Year Multimillion Dollar Deal – Business Wire (press release)

Posted: at 3:47 pm

TORTOLA, British Virgin Islands--(BUSINESS WIRE)--Juvenescence Limited (Juvenescence) is pleased to announce the launch of a joint venture with Insilico Medicine, Inc. (Insilico Medicine), a Baltimore-based company using artificial intelligence (AI) principally focusing on ageing and age-related diseases. The new joint venture, Juvenescence AI Limited (Juvenescence AI), will focus on developing a pipeline of new compounds licensed from Insilico Medicine and on building AI-driven tools for clinical development. This partnership will produce commercially attractive drugs for Juvenescence AI while validating Insilico Medicines innovative AI approach for drug discovery. Juvenescence made an undisclosed investment into Insilico Medicine simultaneously with the creation of the joint venture.

We are very pleased to partner with Alex Zhavoronkov and his team at Insilico Medicine. Artificial intelligence is set to increase efficiencies in many sectors, something sorely needed in drug development as evidenced by the prolonged decline in the sectors productivity. Insilico Medicines approach has massive potential to reduce the cost associated with the discovery of new drugs, said Juvenescences Chairman, Jim Mellon, adding, We are excited by the potential for AI to streamline the longest and most costly portions of the drug development cycle: clinical trials. With Insilico Medicines help, we hope Juvenescence AI will both develop therapeutics that treat the diseases that plague all of us as we age and eventually treat the ageing process itself.

The principals of Juvenescence, Jim Mellon, Dr. Greg Bailey and Dr. Declan Doogan, have extensive track records in drug development, company formation, and biotech investment. The Juvenescence executive and scientific team hopes to combine the classical drug development expertise earned through careers in the pharmaceutical industry and through their successful early investments in companies such as Medivation and Biohaven Pharmaceuticals (NYSE:BHVN), to bear on the new prospects presented by AI-assisted drug development. The team believes that advances in AI provide new avenues for clinical, regulatory and commercial success. Dr. Doogan, the former Senior VP of Clinical Development at Pfizer and current Chairman of Biohaven Pharmaceuticals (NYSE:BHVN), said:

The application of AI techniques to drug discovery has enormous potential and could dramatically alter the way that we discover new drugs and define existing diseases. AI could decrease the cost and increase the speed with which we can bring new medicines to patients."

Juvenescence AI has agreed to license selected novel and repurposed compound families from Insilico Medicine on an ongoing basis, with the aim of developing therapies for both ageing itself and the diseases of ageing, such as diabetes, dementia, cancer, respiratory disease and cardiovascular disease, that increasingly burden our health systems as the worlds population continues to age.

The team at Juvenescence AI has demonstrated extraordinary foresight in recognising that the anti-ageing sector is currently experiencing a period of rapid advance, with vast sums of capital set to flow into the sector in coming years. They have also recognised the potential of AI early and that it will play a key role in adding billions of healthy life years to the lives of people around the globe. We are eager to work with them to develop life-saving and life-extending drugs, said Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine, Inc. and Chief of Artificial Intelligence of Juvenescence AI.

About Juvenescence Limited

Juvenescence Limited is an investment company focussed on therapies to increase human longevity and complementary investments in related sectors. It was founded in 2017 by Jim Mellon, Greg Bailey,Declan Doogan, Anthony Chow, and Alexander Pickett. The Juvenescence team are highly experienced entrepreneurs and investors with a significant focus on the life science and commercial drug development sectors. Juvenescence creates new ventures and invests directly in both startup and established longevity related companies while offering strategic advice and operational support.

Juvenescence believes that advances in science have made real the possibility of slowing, halting or potentially reversing some elements of ageing. Juvenescence believes that the resulting increase in life expectancy will have profound implications on all sectors and in particular healthcare, education, insurance and leisure.

http://www.juvenescence.life

About Juvenescence AI Limited

Juvenescence AI Limited is a drug development and artificial intelligence company focussed on ageing and age-related diseases. Juvenescence AI combines advances in artificial intelligence with classical development expertise in order to prioritise and develop compounds from Insilico Medicine, Incs end-to-end automated drug discovery pipeline through to clinical proof of concept.

http://www.juvenescence.ai

About Insilico Medicine, Inc.

Insilico Medicine, Inc. is an artificial intelligence company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore, with R&D resources in Belgium, Russia, and the UK sourced through hackathons and competitions. The company utilises advances in genomics, big data analysis, and deep learning for in silico drug discovery and drug repurposing for ageing and age-related diseases. The company is pursuing internal drug discovery programs in cancer, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and ageing. Through its Pharma.AI division, Insilico provides advanced machine learning services to biotechnology, pharmaceutical, and skin care companies, foundations and national governments globally. In 2017, NVIDIA selected Insilico Medicine as one of its Top 5 AI companies in its potential for social impact.

Brief company video: https://www.youtube.com/watch?v=l62jlwgL3v8

See the original post here:
Juvenescence Limited - Artificial Intelligence to Discover Drugs in a Multi-Year Multimillion Dollar Deal - Business Wire (press release)

Posted in Human Longevity | Comments Off on Juvenescence Limited – Artificial Intelligence to Discover Drugs in a Multi-Year Multimillion Dollar Deal – Business Wire (press release)

Fear keeps many eczema patients from using steroid creams – Reuters

Posted: at 3:46 pm

(Reuters Health) - Many people with eczema, a common skin disease, may avoid creams and ointments that can help ease symptoms like itching and inflammation because theyre afraid to try topical corticosteroids, a recent study suggests.

Eczema, also known as atopic dermatitis, usually develops in early childhood and often runs in families. Scaly, itchy rashes are the main symptoms. The condition can be treated using moisturizers, avoiding certain soaps and other irritants and with prescription creams and ointments containing corticosteroids to relieve itching.

For the study, researchers examined results from 16 previously published studies and found as many as four in five people were afraid to use corticosteroids for eczema. Between one third and one half of people who were prescribed steroid creams but also expressed concerns about them did not adhere to the treatment - meaning they didnt use the creams and missed out on their benefits.

Steroids have developed a bad reputation because of the potential side effects that come with improper or chronic use of high-potency steroids, said senior study author Dr. Richard Antaya, director of pediatric dermatology at Yale School of Medicine in New Haven, Connecticut.

Common side effects of corticosteroids can include stretch marks as well as thinning, thickening or darkening of the skin. Less often, these steroids can cause acne or infected hair follicles or more serious side effects in the eyes like glaucoma and cataracts.

The resistance to using topical corticosteroids is definitely partly driven by the confusion over the adverse effects of long term use of high potency steroids versus those of short term use of low potency steroids, Antaya said by email. The risks from using short-term low potency steroids are vastly lower.

For the study, Antaya and colleagues examined studies published from 1946 to 2016 that surveyed patients and caregivers about their opinions of topical corticosteroids. The studies included in the analysis were done in Australia, Canada, Croatia, France, Germany, Hong Kong, Japan, Korea, Mexico, the Netherlands, Poland, Singapore and the U.S.

Two studies compared how often patients used these medicines based on whether or not they had phobias.

In one of these studies, 49 percent of people with phobias didnt adhere to a prescribed steroid cream, compared with 14 percent of patients without concerns. In the second study, 29 percent of people with phobias didnt use their steroid cream, compared with 10 percent of patients who werent worried.

Five of the studies in the analysis looked at why people had phobias and found skin thinning was the most frequent concern, followed by fear that steroids might affect growth and development. Some previous research has found long-term use at high doses may impact growth and development in children.

Limitations of the study include the wide variety of phobia definitions used across the 16 smaller studies in the analysis, the authors note in JAMA Dermatology.

Even so, the findings add to evidence that phobias keep many parents in many parts of the world from using corticosteroids to treat their children with eczema, said Dr. Saxon Smith, a dermatologist at the School of Medicine at the University of Sydney in Australia.

It is critical to recognize the high frequency of fears patients and parents have about using topical corticosteroids, Smith, who wasnt involved in the study, said by email.

Left untreated, eczema doesnt just leave kids itchy, Smith said. Itchy and discomfort can be so severe that kids dont sleep at night, impacting normal development and socialization.

Too often we see infants who suffer and have not slept for months and parents exhausted just because they have wrong fear or beliefs about the treatment or the disease and dont treat their child, Dr. Helene Aubert-Wastiaux, a dermatologist at Nantes University Hospital in France who wasnt involved in the study, said by email.

SOURCE: bit.ly/2tZvKrU JAMA Dermatology, online July 19, 2017.

Read this article:
Fear keeps many eczema patients from using steroid creams - Reuters

Posted in Eczema | Comments Off on Fear keeps many eczema patients from using steroid creams – Reuters

Top 5 Eczema Triggers You Should Know – Doctor NDTV

Posted: at 3:46 pm

Knowing your eczema triggers always helps keep your symptoms under control. Read on to find out the top 5 triggers to avoid!

Stress is a common eczema trigger.

1. Dry skin, which may be due to dry winter weather, dry air, or long and hot showers. Remember to always keep your skin moisturized, and preferably, use a thick moisturizer!

2. Foods containing preservatives and artificial ingredients like foods high in trans-fats, such as margarine, processed food, and fast food. Foods high in sugar like confectioneries, sodas, or some fast food items may also trigger eczema flare-ups.

3. Irritants like hand and dish soap, laundry detergent, shampoo, bubble bath and body wash, or surface cleaners and disinfectants. Even some natural liquids, like the juice from fresh fruit, vegetables, or meats, can irritate your skin when you touch them. Some chemicals like household cleaners or even hair dyes may trigger a reaction as well. Certain fabrics like wool or synthetic fabrics like nylon may cause irritation too.

4. Stress, because usually emotional stress tends to cause a flare up. Conversely, feeling stressed because of having eczema can make your skin flare up as well.

5. Sweating, as it tends to aggravate the skin. Stay cool, and stay hydrated. Moreover, always apply sunscreen, and try to avoid going out in harsh, sunny weather.

Also read: 7 Self-Care Tips For People With Eczema

Read the original here:
Top 5 Eczema Triggers You Should Know - Doctor NDTV

Posted in Eczema | Comments Off on Top 5 Eczema Triggers You Should Know – Doctor NDTV

Medicine’s Movable Feast: What Jumping Genes Can Teach Us about Treating Disease – Scientific American

Posted: at 3:46 pm

When the groundbreaking geneticist Barbara McClintock was born in Hartford, Connecticut, in 1902, her parents initially named her Eleanor. But they soon felt that the name was too delicate for their daughter and began to call her Barbara instead, which they thought better suited her strong personality. Her parents accurately predicted her determination.

To say that McClintock was a pioneer is an understatement. In 1944, she became the third woman to be elected to the US National Academy of Sciences and the first woman to lead the Genetics Society of America. Shortly afterwards, she discovered that certain genetic regions in maize could jump around the chromosome and, consequently, influence the color of mottled ears of maize with kernels ranging from golden yellow to dark purple. She dubbed these jumping bits of genetic code controlling units, which later became known as transposons or transposable elements. Unfortunately, by the mid-1950s, McClintock began to sense that the scientific mainstream was not ready to accept her idea, and she stopped publishing her research into this area to avoid alienation from the scientific establishment. But scientific ideas can re-emerge and integrate into the mainstream, and 30 years later, McClintock received a Nobel Prize in Physiology or Medicine for her revolutionary insights into these moving chunks of genetic code.

In recent years, medical research has uncovered new evidence showing that moving parts of the genome in humans can contribute to life-threatening diseases ranging from cancer to diabetes. For example, a handful of hemophilia cases have been traced to transposable elements that, at some point before the patient was born, or even, perhaps, conceived, inserted themselves into and disrupted genes that facilitate blood clotting. At the same time, experiments also offer mounting data to suggest that some transposable elementsand the genes that these roving bits of DNA help to resurrecthave beneficial roles.

The study of transposable elements is a hotbed of research, according to Josh Meyer, a postdoctoral fellow who studies these bits of DNA at Oregon Health & Science University in Portland. Way back in the mists of time for the field, the general category of these things was junk DNA, he explains. Now, he says, researchers have begun to understand that transposable elements aren't always neutral genetic components: There's nothing that transposon biologists love more than to have the discussion of whether these things are, on balance, bad for us or good for us.

Since McClintock's breakthrough, researchers have identified different classes of transposable elements in the genomes of every organism in which they have sought them, ranging from fruit flies to polar bears. About 3% of the human genome consists of transposons of DNA origin, which belong to the same class as the ones that McClintock studied in maize. The other type of transposable elements, known as retrotransposons, are more abundant in our genome. These include the transposable elements that originate from viruses and make up as much as 10% of the human genome1. These elements typically trace back many millennia. They arise when viruses integrate into the genome of sperm or egg cells, and thus get passed down from one generation to the next.

The ancient viruses that became 'fossilized' in the genome remain dormant for the most part, and degenerate over time. However, there are hints that they might have the ability to re-emerge and contribute to illnesses that some scientists say could include autoimmune disease and schizophrenia2. In one example, a 2015 study found elevated levels of one embedded virus, known as human endogenous retrovirus K, in the brains of individuals with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease3. However, researchers stress that the data do not yet establish a causal link.

Yet another category of retrotransposons, called long interspersed nuclear elements-1, or LINE-1 for short, make up a whopping 17% or more of the human genome4. When LINE-1 retrotransposons move within the genome of reproductive cells and insert themselves in new places, they can disrupt important genes. Researchers have so far identified more than 120 LINE-1 gene insertions, resulting in diseases ranging from muscular dystrophy to cystic fibrosis5.

Much of the focus on transposable elementsand particularly, on endogenous retroviruses and LINE-1shas centered on the possible negative repercussions of these DNA insertions. But work tracing back to the 1980s has suggested that endogenous retroviruses may also support reproductive function in some way6. In 2000, scientists found that remnants of an ancient virus in the human genome encode a protein called syncytin, which cell experiments indicate is important for placental development7. And although it is not shown definitely, there are also hints that an endogenous retrovirus that became embedded in the DNA of a primate ancestor might help boost the production of the digestive enzyme amylase, which helps to break down starch, in our saliva8, 9.

To peer deeper into the effects of transposable elements in humans, geneticist Nels Elde and his colleagues at the University of Utah in Salt Lake City used CRISPRCas9 gene editing to target an endogenous retrovirus called MER41, thought to come from a virus that integrated into the genome perhaps as far back as 60 million years ago. The scientists removed the MER41 element from human cells cultured in a dish. In humans, MER41 appears near genes involved in responding to interferon, a signaling molecule that helps our immune response against pathogens. Notably, as compared with normal cells, cells engineered to lack MER41 were more susceptible to infection by the vaccinia virus, used to inoculate people against smallpox. The findings, reported last year, suggest that MER41 has a crucial role in triggering cells to launch an immune response against pathogens through the interferon pathway10.

Meyer stresses that these insights elevate the already eminent discoveries by McClintock. I would hope she would be extremely gratified and vindicated, he says. She recognized a type of sort of factor of genomic dynamism that no one else had seen before. And I am firmly convinced that it's going to only become more and more and more central to our understanding of how genomics works.

In 2005, with a freshly minted doctorate in molecular genetics, Nels Elde landed a job as a research fellow in Seattle and was tasked with studying the evolution of the immune system of gibbons, a type of ape. Each morning as he biked to the lab downtown, he would pass the city's zoo and hear its gibbons calling to each other. Occasionally, he would visit the zoo and look at them, but he had no idea at the time that the squirrel monkeys that he also saw there would feature so largely in his future research. At work, Elde's primate investigations focused on the gibbon DNA that he was responsible for extracting and analyzing using sequencing machinery.

Then, six years ago, Elde received his first lab of his own to run, at the University of Utah. He did not expect his team's first discovery there to come so swiftly, or that it would involve transposable elements. Elde had arrived at the university with the intention of learning how cells recognize and defeat invading viruses, such as HIV. But he hadn't yet obtained the equipment that he needed to run experiments, despite already having two employees who were eager to do work, including his lab manager, Diane Downhour. Given the lack of lab tools, the two lab staff members spent their time on their computers, poking around databases for interesting patterns in DNA. After just two weeks of this, Downhour came into Elde's office and told him that they had found a couple of extra copies of a particular gene in New World monkeysspecifically, in squirrel monkeys.

Elde initially brushed off Downhour's insight. I said, 'Why don't you go back to the lab and not worry about it?' he recalls. But a couple of days later, she returned to his office with the idea. I was just in the sort of panicked mode of opening a lab, ordering freezers, trying to set up equipment and hiring people, Elde explains. Diane definitely had to come back and say, 'Come on, wake up here. Pay attention.'

The gene that they detected multiple copies of in squirrel monkeys is called charged multivesicular body protein 3, or CHMP3. Each squirrel monkey seems to have three variants of the gene. By comparison, humans have only the one, original variant of CHMP3. The gene is thought to exist in multiple versions in the squirrel monkey genome thanks to transposable elements. At some point around 35 million years ago, in an ancestor of the squirrel monkey, LINE-1 retrotransposons are thought to have hopped out of the genome inside the cell nucleus and entered the cytoplasm of the cell. After associating with CHMP3 RNA in the cytoplasm, the transposable elements brought the code for CHMP3 back into the nucleus and reintegrated it into the genome. When the extra versions of CHMP3 were copied into the genome, they were not copied perfectly by the cellular machinery, and thus changes were introduced into the sequences. Upon a first look at the data, these imperfections seemed to render them nonfunctional 'pseudogenes'. But as Elde's team delved into the mystery of why squirrel monkeys had so many copies of CHMP3, an intriguing story emerged.

The discovery of pseudogenes is not wholly uncommon. There are more than 500,000 LINE-1 retrotransposons in the human genome11, and these elements have scavenged and reinserted the codes for other proteins inside the cell as well. Unlike with the endogenous retroviral elements in the genome, which can be clearly traced back to ancient viruses, the origin of LINE-1 retrotransposons is murky. However, both types of transposable elements contain the code for an enzyme called reverse transcriptase, which theoretically enables them to reinsert genetic code into the genome in the cell nucleus. This enzyme is precisely what allowed LINE-1 activity to copy CHMP3 back into the genome of the squirrel-monkey ancestor.

Elde couldn't stop thinking about the mystery of why squirrel monkeys had multiple variants of CHMP3. He knew that in humans, the functional variant of the CHMP3 gene makes a protein that HIV uses to bud off of the cell membrane and travel to and infect other cells of the body. A decade ago, a team of scientists used an engineered vector to prompt human cells in a dish to produce a truncated, inoperative version of the CHMP3 protein and showed that the truncated protein prevented HIV from budding off the cells12. There was hope that this insight would yield a new way of treating HIV infection and so prevent AIDS. Unfortunately, the protein also has a role in allowing other important molecular signals to facilitate the formation of packages that bud off of the cell membrane. As such, the broken CHMP3 protein that the scientists had coaxed the cells to produce soon caused the cells to die.

Given that viruses such as HIV use a budding pathway that relies on normal CHMP3 protein, Elde wondered whether the extra, altered CHMP3 copies that squirrel monkeys carry confers some protection against viruses at the cellular level. He coordinated with researchers around the globe, who sent squirrel-monkey blood from primate centers as far-reaching as Bastrop, Texas, to French Guiana. When Elde's team analyzed the blood, they found that the squirrel monkeys actually produced one of the altered versions of CHMP3 they carry. This finding indicated that in this species, one of the CHMP3 copies was a functional pseudogene, making it more appropriately known as a 'retrogene'. In a further experiment, Elde's group used a genetic tool to coax human kidney cells in a dish to produce this retrogene version of CHMP3. They then allowed HIV to enter the cells, and found that the virus was dramatically less able to exit the cells, thereby stopping it in its tracks. By contrast, in cells that were not engineered to produce the retrogene, HIV was able to leave the cells, which means it could theoretically infect many more.

In a separate portion of the experiment Elde's group demonstrated that whereas human cells tweaked to make the toxic, truncated version of CHMP3 (the kind originally engineered a decade ago) die, cells coaxed to make the squirrel-monkey retrogene version of CHMP3 can survive. And by conducting a further comparison with the truncated version, Elde found that the retrogenewhat he calls retroCHMP3in these small primates had somehow acquired mutations that resulted in a CHMP3 protein containing twenty amino acid changes. It's some combination of these twenty points of difference in the protein made by the retrogene that he thinks makes it nontoxic to the cell itself but still able to sabotage HIV's efforts to bud off of cells. Elde presented the findings, which he plans to publish, in February at the Keystone Symposia on Viral Immunity in New Mexico.

The idea that retroCHMP3 from squirrel monkeys can perhaps inhibit viruses such as HIV from spreading is interesting, says Michael Emerman, a virologist at the Fred Hutchinson Cancer Research Center. Having an inhibitor of a process always helps you understand what's important for it, Emerman explains. He adds that it's also noteworthy that retroCHMP3 wasn't toxic to the cells, because this finding could inspire a new antiviral medicine: It could help you to design small molecules or drugs that could specifically inhibit that part of the pathway that's used by viruses rather than the part of the pathway used by host cells.

Akiko Iwasaki, an immunologist at the Yale School of Medicine in New Haven, Connecticut, is also optimistic that the finding will yield progress. What is so cool about this mechanism of HIV restriction is that HIV does not bind directly to retroCHMP3, making it more difficult for the virus to overcome the block imposed by retroCHMP3, Iwasaki says. Even though humans do not have a retroCHMP3 gene, by understanding how retroCHMP3 works in other primates, one can design strategies to mimic the activity of retroCHMP3 in human cells to block HIV replication.

Elde hopes that, if the findings hold, cells from patients with HIV infection might one day be extracted and edited to contain copies of retroCHMP3, and then reintroduced into these patients. Scientists have already used a similar cell-editing approach in clinical trials to equip cells with a variant of another gene, called CCR5, that prevents HIV from entering cells. In these experiments, patients have received infusions of their own cellsmodified to carry the rare CCR5 variant. But although preliminary results indicate that the approach is safe, there is not enough evidence yet about its efficacy. (Another point of concern is that people with the rare, modified version of the CCR5 gene might be as much as 13 times more susceptible to getting sick from West Nile virus than those with the normal version of this gene13.) By editing both retroCHMP3 and the version of CCR5 that prevents HIV entry into cells, Elde suggests, this combination of gene edits could provide a more powerful way of modifying patient cells to treat HIV infection.

You could imagine doing a sort of cocktail genetic therapy in order to block HIV in a way that the virus can't adapt around it, Elde says. His team also plans to test whether retroCHMP3 has antiviral activity against other viruses, including Ebola.

The investigations into how pseudogenes and retrogenes might influence health are ongoing. And there is mounting evidence that the LINE-1 elements that create them are more active than previously thought. In 2015, for example, scientists at the Salk Institute in California reported a previously unidentified region of LINE-1 retrotransposons that are, in a way, supercharged. The region that the researchers identified encodes a protein that ultimately helps the retrotransposons to pick up bits of DNA in the cell cytoplasm to reinsert them into the genome14. The same region also enhances the ability of LINE-1 elements to jump around the genome and thus create variation, adding weight to the idea that these elements might have an underappreciated role in human evolution and in creating diversity among different populations of people.

The active function of transposable elements is more important than many people realize, according to John Coffin, a retrovirus researcher who divides his time between his work at the US National Cancer Institute in Frederick, Maryland, and Tufts University in Boston. They canand havecontributed in important ways to our biology, he says. I think their role in shaping our evolutionary history is underappreciated by many evolutionary biologists.

Squirrel monkeys are not the only animals that might reap protection against viral invaders thanks in part to changes in the genome caused by transposable elements. In 2014, Japanese scientists reported on a chunk of Borna virus embedded in the genome of ground squirrels (Ictidomys tridecemlineatus). The team's results from cellular experiments suggest that this transposed chunk encodes a protein that might interfere with the pathogenicity of external Borna viruses that try to invade these animals15. Humans also have embedded chunks of Borna virus in their genomes. But we don't have the same antiviral version that the ground squirrels haveand we might therefore be less protected against invading Borna viruses.

Other studies of endogenous viruses might have clearer implications for human health, and so scientists are looking at the activity of these transposable elements in a wide range of other animals, including the house cat. This past October, another group of Japanese researchers found that viruses embedded in the genomes of domesticated cats have some capacity to replicate. This replication was dependent on how well the feline cells were able to squelch the endogenous viruses in the genome through a silencing process called methylation16. But perhaps the most striking example of a replicating endogenous retrovirus is in koalas. In the 1990s, veterinarians at Dreamworld, a theme park in Queensland, Australia, noticed that the koalas were getting lymphoma and other cancers at an alarming rate. The culprit turned out to be a retrovirus that was jumping around in the animals' genomes and wreaking havoc. Notably, koalas in the south of the country showed no signs of the retrovirus, which suggests that the virus had only recently begun to integrate into these animals' DNA17.

The risks of transposable elements to human health are a concern when it comes to the tissue transplants we receive from other species, such as from pigs, which have porcine endogenous retroviruses. These embedded viruseswhich have the unfortunate abbreviation PERVscan replicate and infect human cells.

Transplants from pigs, for example, commonly include tissues such as tendons, which are used in ACL-injury repair. But these tissues are stripped of the pig cellsand thus of PERVsso that just the tissue scaffold remains. However, academic institutions and companies are actively designing new ways to use pig tissues in humans. Earlier this year, Smithfield Foods, a maker of bacon, hotdogs and sausages, announced it had launched a new bioscience unit to help supply pig parts to medical companies in the future. Meanwhile, George Church, a Harvard Medical School geneticist and entrepreneur, has formed a company called eGenesis Bio to develop humanized pigs for tissue transplantation. In March, the company announced that it had raised $38 million in venture funding. Church published a paper two years ago showing that his team had edited out key bits of 62 PERVs from pig embryos, disrupting the PERVs' replication process and reducing their ability to infect human cells by 1,000-fold18.

Whereas Church and other scientists have tried disrupting endogenous retroviruses in animal genomes, researchers have also experimented with resurrecting them: a decade ago, a group of geneticists in France stirred up some controversy when the researchers recreated a human endogenous retrovirus by correcting the mutations that had rendered it silent in the genome for millennia. The scientists called it the 'Phoenix' virus, but it showed only a weak ability to infect human cells in the lab19. There was, perhaps unsurprisingly, pushback against the idea of resurrecting viruses embedded in our genomeno matter how wimpy the resulting viral creation.

But emerging data suggest that the retroviruses buried in the human genome might not be quite as dormant as we thought. The ability for these endogenous retroviruses to awaken from the genome is more widespread than has been previously appreciated, says virologist Rene Douville at the University of Winnipeg in Canada. She views this phenomenon as being the rule, rather than the exception within the cell: These retroelements are produced from the genome as part of the cell's normal function to varying degrees.

Interestingly, the cellular machinery involved in keeping cancer at bay might also have a connection to transposable elements. One in three binding sites in the human genome for the important tumor-suppressor protein p53 are found within endogenous retroviruses in our DNA20. And last year, a team led by John Abrams at University of Texas Southwestern Medical Center in Dallas offered preliminary evidence that p53 might do its work by perhaps keeping embedded retroelements in check21.

When I first started openly publicly talking about this story, some of my colleagues here who are in the cancer community said, 'Hey, that's cute, but it can't be true. And the reason it can't be true is that we would know this already,' Abrams recalls. The reason it wasn't seen before, he explains, is that many genetic analyses throw out repeated sequenceswhich often consist of retroelements. So his team had to go dumpster diving in the genetic databases for these sequences of interest to demonstrate the link to p53. Abrams suspects that when p53 fails to keep retrotransposons at bay, tumors might somehow arise: The next question becomes, 'How do you get to cancer?' Abrams says that this is an example of what he calls transposopathies.

Not all scientists are convinced of a causal link between p53 and retroelements in cancer. My question is, if p53 is so vital in suppressing retrotransposon activity in cancer, why do we not find evidence of dysregulated retrotransposons inserting copies of themselves into the tumor genome more often? asks David Haussler, a genomics expert at the University of California, Santa Cruz. Most tumors have p53 mutations, yet only a very small percentage of tumors show evidence of significantly dysregulated rates of new retrotransposon copy insertion.

Still, there are others interested in exploring whether ancient viruses might reawaken in cancer or have some other role in this disease. Five years ago, scientists at the University of Texas MD Anderson Cancer Center reported that a type of viral protein produced by the human endogenous retrovirus type K (HERV-K) is often found on the surface of breast cancer cells. In a mouse experiment, they showed that cancers treated with antibodies against this protein grew to only one-third of the size of tumors that did not receive this therapy22.

But some cancer scientists are thinking about co-opting endogenous retroviruses to use against cancer. Paul Bieniasz of the Rockefeller University in New York City gained insight into this approach by studying human endogenous retrovirus type T (HERV-T)an ancient virus that spread for 25 million years among our primate ancestors until its extinction roughly 11 million years ago and at some point became fossilized in our DNA lineage. In April, his group found that a particular HERV-T encodes a protein that blocks a protein called monocarboxylate transporter 1, which is abundant on the surface of certain types of cancer cells23. It's thought that monocarboxylate transporter 1 has a role in enabling tumors to grow. Blocking it could help to stymie the expansion of malignancies, Bieniasz speculates. He and his colleagues are now trying to build an 'oncolytic virus' that uses elements of HERV-T to treat cancer.

The idea that new viruses might still be trying to creep into our genomes is a scary one, even if they don't appear very effective at achieving this. One of the most recent to integrate into our genome in a way that it is passed down from generation to generation is human endogenous retrovirus type K113 (HERV-K133), which sits on chromosome 19. It's found in only about one-third of people worldwide, most of whom are of African, Asian or Polynesian background. And researchers say that it could have integrated into the genome as recently as 200,000 years ago6.

Although experts remain skeptical that a virus will integrate into the human genome again anytime soon, other transposable elements, such as LINE-1s, continue to move around in our DNA. Meanwhile, the field that Barbara McClintock seeded more than half a century ago is growing quickly. John Abrams, who is studying retroelements, says that we're only just beginning to understand how dynamic the genome is. He notes that only recently have people begun to appreciate how the 'microbiome' of bacteria living in our guts can influence our health. We're really an ecosystem, Abrams says of the gut, and the genome is the same way. There is the host DNAbelonging to usand the retro-elements it contains, he explains, and there's this sort of productive tension that exists between the two.

This article is reproduced with permission and wasfirst publishedon July 11, 2017.

Continue reading here:
Medicine's Movable Feast: What Jumping Genes Can Teach Us about Treating Disease - Scientific American

Posted in Gene Medicine | Comments Off on Medicine’s Movable Feast: What Jumping Genes Can Teach Us about Treating Disease – Scientific American

3 Genetics Tests To Improve Prenatal Screening – HuffPost

Posted: at 3:46 pm

This article is authored by the Mayo Clinic Center for Individualized Medicine. The mission of the Center is to discover and integrate the latest in genomic, molecular and clinical sciences into personalized care for patients.

New technology is reshaping prenatal screening to assess the health of a developing baby. Now pregnant women can have their baby initially screened for genetic disorders, such as Down syndrome, through the use of a newer blood test that evaluates DNA present in the mothers blood stream. Another test for couples planning a family uses a single blood sample to assess whether future children might be at risk for developing a genetic disease.

Its an exciting time in perinatal testing, explains Myra Wick, M.D., Ph.D. DNA sequencing and molecular technology have improved and become more cost effective. These tests are important for family planning before pregnancy as well as planning for the care of a baby who is found to have a genetic disorder during pregnancy.

Researchers from Mayo Clinic and the Center for Individualized Medicine have helped implement several of these tests, which use a personalized medicine approach to perinatal screening. Three state-of-the-art perinatal genetic tests are becoming more widely available to expectant parents.

Mayo Medical Laboratories recently launched a blood test to screen for the most common chromosome disorders diagnosed in pregnancy, such as Down syndrome. Its known as a cell-free DNA test. It screens the mothers blood that contains DNA from the baby, looking for genetic disorders in the fetus. The new test generally has a higher detection rate and fewer false positives than traditional screening tests.

Prior to this new test, mothers had the option of traditional first trimester screening, which is a blood test and ultrasound, or second trimester screening, which is a blood test. In general, the cell free DNA blood test can be used in place of the traditional first and second trimester screening, explains Dr. Wick. It is important to remember that the cell free DNA testing is a screening test, and abnormal results should be followed up with additional testing.

The out-of-pocket cost for the new blood test varies depending on insurance coverage, and the specific laboratory performing the testing; a general estimate is approximately $350. Results are usually ready within one week.

2. Expanded carrier screening

In the past, couples had genetic screening based on family history of a genetic disorder, or if they were part of an ethnic group at risk for certain inherited diseases. Previous tests only screened for a small defined group of genetic disorders. Those tests didnt help couples who were uncertain of their ethnic heritage, plus the tests were very limited in scope.

---------------------------

Its an exciting time in perinatal testing. DNA sequencing and molecular technology has improved and become more cost effective. These tests are important for family planning prior to pregnancy as well as planning for the care of a child who is found to have a genetic disorder during pregnancy. - Dr. Myra Wick

--------------------------

Now couples may choose a more comprehensive test that looks for 100 or more genetic disorders. Its called expanded carrier screening. This test is done with a blood sample from each prospective parent.

Expanded carrier screening looks at multiple genes associated with genetic diseases. Most of the disorders included on an expanded carrier screen are inherited in an autosomal recessive manner. This means that the parents are carriers of the disorder, with one normal copy of the gene and one abnormal copy of the gene. Carriers of an autosomal recessive disorder do not typically have signs or symptoms of the disease. A child is affected with an autosomal recessive disorder when he or she inherits one abnormal copy of the gene from mom, and one abnormal copy of the gene from dad. Approximately 5% of couples who undergo expanded carrier screening are found to be carriers for the same disorder, and at risk for having an affected says Dr. Wick.

Depending upon insurance coverage, the test costs approximately $350. Test results are returned within one to two weeks.

3. Whole exome sequencing (WES)

In rare cases, an ultrasound during pregnancy reveals that the baby has several medical problems. Traditional genetic testing may not identify a diagnosis. Now whole exome sequencing (WES), which looks at most of the genes linked to growth and health, can be used to evaluate the fetuss condition. It can provide a diagnosis in 30 percent of cases.

For this testing, an amniocentesis is performed first to obtain DNA for genetic analysis.

We are beginning to use WES even before the baby is born. Results can be used to plan for care of an infant who may be born with several complex medical concerns. In addition, parents can use this information for future family planning, says Dr. Wick.

Whole exome sequencing is expensive, with typical costs of approximately $8,000, depending upon the specific test and insurance coverage. Results from this more complex screening usually take several weeks, depending upon the specific test being used.

Dr. Wicks suggests that you ask your health care provider about genetic testing and recommends that all prospective and expectant parents consult with a medical geneticist or genetic counselor before genetic screening.

If your provider is at a large medical center, genetic counseling should be available. At smaller facilities, your primary provider may order initial blood tests, but you may be referred to a larger facility if test results indicate you need genetic counseling.

See more here:
3 Genetics Tests To Improve Prenatal Screening - HuffPost

Posted in Gene Medicine | Comments Off on 3 Genetics Tests To Improve Prenatal Screening – HuffPost